World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
76
Citations
24183
World Ranking
1401
National Ranking
40

Medicine

D-Index
78
Citations
25362
World Ranking
17945
National Ranking
597

Overview

Monica A. Slavin is affiliated with the Peter MacCallum Cancer Centre in Australia, with a focus on medicine and infectious diseases in oncology. Their primary research areas encompass epidemiology, infectious diseases, and oncology, with significant contributions to clinical biochemistry and pharmacology.

Their recent research includes studies published in prominent journals such as The Lancet Infectious Diseases, Clinical Infectious Diseases, The Medical Journal of Australia, and The Lancet Oncology. Notable papers include:

  • Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology (2021, The Lancet Infectious Diseases)
  • The Penicillin Allergy Delabeling Program: A Multicenter Whole-of-Hospital Health Services Intervention and Comparative Effectiveness Study (2020, Clinical Infectious Diseases)
  • Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance (2020, The Medical Journal of Australia)
  • 8th European Conference on Infections in Leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell transplantation (2021, The Lancet Oncology)
  • Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum (2024, Clinical Infectious Diseases)

Monica A. Slavin has collaborated frequently with a range of researchers, including:

  • Karin Thursky (60 joint publications)
  • Benjamin W. Teh (51 joint publications)
  • Michelle K. Yong (35 joint publications)
  • Gabrielle M. Haeusler (27 joint publications)
  • Leon J. Worth (26 joint publications)

Their works are commonly published in leading infectious disease and antimicrobial journals, with multiple publications appearing in:

  • Transplant Infectious Disease (24 publications)
  • Open Forum Infectious Diseases (15 publications)
  • Journal of Antimicrobial Chemotherapy (11 publications)
  • Clinical Infectious Diseases (9 publications)
  • Internal Medicine Journal (9 publications)

Main topics covered in their research include:

  • Antifungal resistance and susceptibility
  • Fungal infections and studies
  • Neutropenia and cancer infections
  • Cytomegalovirus and herpesvirus research
  • Bacterial identification and susceptibility testing
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Infectious diseases and mycology

Best Publications

  • Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

    J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach

  • Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

    Oliver A. Cornely;Ana Alastruey-Izquierdo;Dorothee Arenz;Sharon C. A. Chen

  • Efficacy and Safety of Fluconazole Prophylaxis for Fungal Infections after Marrow Transplantation—A Prospective, Randomized, Double-Blind Study

    M A Slavin;B Osborne;R Adams;M J Levenstein

  • The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports.

    W. Jeong;C. Keighley;C. Keighley;R. Wolfe;W.L. Lee

  • Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial.

    Kieren A. Marr;Kristy Seidel;Monica A. Slavin;Raleigh A. Bowden

  • Combination antifungal therapy for invasive aspergillosis a randomized trial

    Kieren A. Marr;Haran T. Schlamm;Raoul Herbrecht;Scott T. Rottinghaus

  • Echinocandin antifungal drugs in fungal infections: a comparison

    Sharon C. A. Chen;Monica A. Slavin;Tania C. Sorrell

  • Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology

    Martin Hoenigl;Jon Salmanton-García;Thomas J. Walsh;Thomas J. Walsh;Marcio Nucci

  • European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia

    J.A. Maertens;C. Girmenia;R.J.M. Bruggemann;R.F. Duarte

  • Treatment of Scedosporiosis with Voriconazole: Clinical Experience with 107 Patients

    Peter Troke;Koldo Aguirrebengoa;Carmen Arteaga;David Ellis

  • Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial

    Orla Morrissey;Orla Morrissey;Sharon C-A Chen;Sharon C-A Chen;Sharon C-A Chen;Tania Christine Sorrell;Tania Christine Sorrell;Tania Christine Sorrell;Sam Milliken

  • Toxoplasma gondii infection in marrow transplant recipients : a 20 year experience

    M A Slavin;J D Meyers;J S Remington;R C Hackman

  • Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients.

    Christopher C. Blyth;Sharon C. A. Chen;Monica A. Slavin;Carol Serena

  • Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine.

    B. P. Howden;M. A. Slavin;A. P. Schwarer;A. M. Mijch

  • Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab*.

    Karin A Thursky;Leon J Worth;Leon J Worth;John F Seymour;H Miles Prince;H Miles Prince

  • Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and death

    Sharon C A Chen;Sharon C A Chen;Sharon C A Chen;Monica Slavin;Christopher Heath;Geoffrey Playford

  • Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.

    E Geoffrey Playford;Deborah Marriott;Quoc Nguyen;Sharon Chen

  • Active surveillance for candidemia, Australia.

    Sharon Chen;Monica Slavin;Quoc Nguyen;Deborah Marriott

  • Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing.

    P. Lewis White;John R. Wingard;Stéphane Bretagne;Jürgen Löffler

  • ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients.

    Cesaro S;Dalianis T;Hanssen Rinaldo C;Koskenvuo M

  • Combination Antifungal Therapy for Invasive Aspergillosis

    Kieren A. Marr;Haran T. Schlamm;Raoul Herbrecht;Scott T. Rottinghaus

Frequent Co-Authors

Sharon C.-A. Chen
Sharon C.-A. Chen Westmead Hospital
Tania C. Sorrell
Tania C. Sorrell University of Sydney
John F. Seymour
John F. Seymour Peter MacCallum Cancer Centre
David Ritchie
David Ritchie Peter MacCallum Cancer Centre
Jeff Szer
Jeff Szer Peter MacCallum Cancer Centre
Deborah Marriott
Deborah Marriott Ascension Health
Andrew Grigg
Andrew Grigg Austin Hospital
Elizabeth J. Phillips
Elizabeth J. Phillips Vanderbilt University Medical Center
Catriona Halliday
Catriona Halliday Westmead Hospital
Sarah Kidd
Sarah Kidd South Australia Pathology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens a variety of career options, many of which intersect with healthcare and data management fields. Beyond laboratory research, professionals can explore roles in health information systems or advanced clinical practice.

For those interested in advancing clinical expertise, becoming a functional nurse practitioner offers a compelling pathway. This role integrates patient care with a focus on holistic treatment approaches, often requiring specialized training beyond a microbiology background.

Alternatively, the healthcare industry has a strong demand for roles like Certified Professional Coders. Understanding medical billing and coding is essential for managing patient information accurately. Exploring the cpc medical coding salary and career paths can provide insight into this field’s financial and growth prospects.

For those interested in data and administrative roles, a bachelor of science in health information management salary reveals competitive compensation for managing healthcare data systems. Online programs, including the best online health information management degree cahiim accredited, provide convenient options to develop expertise in this growing field while pursuing microbiology studies.

Best Scientists Citing Monica A. Slavin

Trending Scientists

Recently Published Articles